Regent Pacific Group Ltd. is an investment holding company. The firm consists of investments in biopharma companies, resources and other corporate investments. It operates through the following segments: Biopharma and Corporate Investment. The Biopharma includes research, development, manufacturing, marketing and sale of pharmaceutical products. The Corporate Investment segment engages in the investment in corporate entities, both listed and unlisted. The company was founded by James Mellon and Jayne Allison Sutcliffe in 1990 and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company